Serial Measurements of Hematologic Counts during the Active Phase of Human Granulocytic Ehrlichiosis

To describe the changes that occur in blood count parameters during the natural course of human granulocytic ehrlichiosis, we designed a retrospective cross-sectional case study of 144 patients with human granulocytic ehrlichiosis and matched controls who had a different acute febrile illness. Patie...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases Vol. 32; no. 6; pp. 862 - 870
Main Authors: Bakken, Johan S., Aguero-Rosenfeld, Maria E., Tilden, Robert L., Wormser, Gary P., Horowitz, Harold W., Raffalli, John T., Baluch, Mehdi, Riddell, Debbie, Walls, Jennifer J., Dumler, J. Stephen
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 15-03-2001
University of Chicago Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To describe the changes that occur in blood count parameters during the natural course of human granulocytic ehrlichiosis, we designed a retrospective cross-sectional case study of 144 patients with human granulocytic ehrlichiosis and matched controls who had a different acute febrile illness. Patients from New York State and the upper Midwest were evaluated from June 1990 through December 1998. Routine complete blood counts and manual differential leukocyte counts of peripheral blood were performed on blood samples that were collected during the active illness, and values were recorded until the day of treatment with an active antibiotic drug. Thrombocytopenia was observed more frequently than was leukopenia, and the risk of having ehrlichiosis varied inversely with the granulocyte count and the platelet count. Patients with ehrlichiosis displayed relative and absolute lymphopenia and had a significant increase in band neutrophil counts during the first week of illness. Knowledge of characteristic complete blood count patterns that occur during active ehrlichiosis may help clinicians to identify patients who should be evaluated specifically for ehrlichiosis and who should receive empiric antibiotic treatment with doxycycline.
Bibliography:ark:/67375/HXZ-V56MT4BB-9
istex:FF303AAC280088C8A855895B851B229A3AB95E02
Presented in part: 37th International Congress of Antimicrobial Agents and Chemotherapy, Toronto, Canada, 28 September–1 October 1997 (abstract K-56).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1058-4838
1537-6591
DOI:10.1086/319350